How many acquisitions has Novartis made so far?

Novartis has completed 43 acquisitions so far, with an average acquisition amount of $2.83B.

Which countries does Novartis usually acquire in?

Novartis has made acquisitions in 7 countries with the most activity in United States and United Kingdom.

Which sectors does Novartis target for acquisitions?

Most of Novartis's acquisitions are in Oncology (10) and Immunotherapy (8).

In which year did Novartis make the most acquisitions?

Novartis was most active in 2024, with 5 acquisitions completed in that year.

List of 43 Acquisitions by Novartis (Jul 2026)

Q: Which is Novartis' latest acquisition?

Novartis's most recent acquisition is Excellergy, a Developer of trifunctional effector cell response inhibitors for allergic diseases, acquired in March 2026.

Most viewed in 2019

Novartis has made a total of 43 acquisitions. It has completed these 43 acquisitions across 23 sectors, including Oncology, Immunotherapy, and Ophthalmology. These transactions span 7 countries, with primary activity in the United States, United Kingdom, and Switzerland. Peak acquisition years occurred in 2016 and 2024 with 5 acquisitions each, followed by 2025 with 4 acquisitions. The average number of acquisitions per year for the 2020–2025 period is 2.8, and 1 acquisition has been completed in the current year. The most recent acquisition, completed in March 2026, is Excellergy, a Palo Alto-based developer of trifunctional effector cell response inhibitors for allergic diseases founded in 2020.

Here's the year on year acquisition history of Novartis:

Number of Total Acquisitions

Year	# Acquisitions
2026	1
2025	4
2024	5
2023	2
2022	1
2021	2
2020	3
2019	1
2018	2
2017	1
2016	5
2015	2
2014	1
2012	1
2011	1
2010	1
2009	2
2008	2
2006	2
2005	2
2002	1
1997	1

View all Acquisitions by Novartis

Recent acquisitions by Novartis

Novartis's most recent acquisition - Excellergy is a Developer of trifunctional effector cell response inhibitors for allergic diseases, founded in 2020 and located in Palo Alto. Novartis acquired it in March 2026 for a price of $*****.

Here is the list of all acquisitions by Novartis sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Mar 27, 2026	Excellergy	vhof	htnr	27	808
Oct 27, 2025	Avidity Biosciences	dn{d	cnji	11	887
Sep 09, 2025	Tourmaline Bio	rasc	rttj	71	537
Apr 30, 2025	Regulus Therapeutics	pwyb	bzxd	92	872
Feb 11, 2025	Anthos Therapeutics	damr	jkfv	92	315